Skip to content

Clinical trials

Myocardial Infarction trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Country / region: Netherlands Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20031
20041
20052
20064
20074
20085
20092
20107
201111
20124
201310
20145
20155
20163
20174
20185
20194
20205
20217
20224
20235
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Unknown status16
Recruiting12
Terminated10
Active, not recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
University Medical Center Groningen5
Novartis Pharmaceuticals4
Radboud University Medical Center4
VieCuri Medical Centre4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Catharina Ziekenhuis Eindhoven3
Foundation of Cardiovascular Research and Education Enschede3
Maastricht University Medical Center3
R&D Cardiologie3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction110
Coronary Artery Disease33
Acute Coronary Syndrome27
Cardiovascular Diseases23
Myocardial Ischemia18
Stroke17
ST Elevation Myocardial Infarction15
Heart Diseases13
Angina, Unstable11
Heart Failure9

Trials

Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.